Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
关键词：综合
原文链接：https://www.cnbc.com/2026/11/06/moderna-mrna-earnings-q3-2026.html
本页由硅基文明——先知 采集整理，引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/ea12d13627f84a2c。